LAZRQ
Luminar Technologies, Inc./DE
No data for this timeframe.
Vol
Inst. Holders8 funds
Inst. Value$11.1M
Inst. Activity0 buys / 6 sells
Insider Activity0B / 1S
Insider Net $-$14.90
SEC Reports3
Recent Activity
Apr 7, 2026
SEC
Luminar Technologies, Inc. has filed Form 15-12G to deregister its Class A common stock and suspend its reporting obliga
15-12G — Impact 7/10
Mar 12, 2026
SEC
Luminar Technologies has had eight separate registration statements (Form S-3ASR) become effective as of March 11, 2026,
EFFECT — Impact 4/10
Mar 10, 2026
Insider
Schiano Dominick sold 266 shares
Director @ $0.0560 ($14.90)
Feb 25, 2026
SEC
Luminar Technologies, Inc. and its affiliated debtors have filed for Chapter 11 bankruptcy and are implementing a Third
8-K — Impact 9/10
Inst.
VANGUARD GROUP INC — EXIT
0 shares ($0.00)
Inst.
FMR LLC — EXIT
0 shares ($0.00)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$2.11
Current $0.0180
Low $0.5000
Median $1.50
High $6.00
7 analysts
$0.5000
$6.00
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.11 ▲ +93.5% | $-0.15 — $-0.08 | 92% YoY | 4 |
| Current FY | $-0.49 ▲ +93.4% | $-0.65 — $-0.28 | 95% YoY | 6 |
Latest Reports
BEARISH
15-12G
7/10
Luminar Technologies, Inc. has filed Form 15-12G to deregister its Class A common stock and suspend its reporting obliga
Apr 7, 2026
NEUTRAL
EFFECT
4/10
Luminar Technologies has had eight separate registration statements (Form S-3ASR) become effective as of March 11, 2026,
Mar 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $8.1M | EXIT |
| UBS Group AG | $1.4M | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $801.9K | EXIT |
| MORGAN STANLEY | $710.9K | EXIT |
| WELLS FARGO & COMPANY/MN | $74.7K | EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 10, 2026 | Schiano Dominick | SELL | $14.90 |
8 institutional holders with $11.1M total value (5,881,507 shares) as of 2025-Q3. Top holders: VANGUARD, UBS, CHARLES. Net buying activity: 4 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 4,234,195 | $8.1M | 72.6% | EXIT -100.0% |
| 2 | UBS Group AG | 738,818 | $1.4M | 12.7% | DOUBLED +253.7% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 419,856 | $801.9K | 7.2% | EXIT -100.0% |
| 4 | MORGAN STANLEY | 372,190 | $710.9K | 6.4% | EXIT -100.0% |
| 5 | WELLS FARGO & COMPANY/MN | 39,117 | $74.7K | 0.7% | EXIT -100.0% |
| 6 | BANK OF AMERICA CORP /DE/ | 22,398 | $42.8K | 0.4% | EXIT -100.0% |
| 7 | FMR LLC | 5,678 | $10.8K | 0.1% | EXIT -100.0% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 49,255 | $95.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | EXIT | 4,234,195 | 0 | -100.0% | $0.00 | 2025-Q4 |
| FMR LLC | EXIT | 5,678 | 0 | -100.0% | $0.00 | 2025-Q4 |
| MORGAN STANLEY | EXIT | 372,190 | 0 | -100.0% | $0.00 | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | EXIT | 22,398 | 0 | -100.0% | $0.00 | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | EXIT | 39,117 | 0 | -100.0% | $0.00 | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 419,856 | 0 | -100.0% | $0.00 | 2025-Q4 |
| VANGUARD GROUP INC | DOUBLED | 1,891,998 | 4,234,195 | +123.8% | $8.1M | 2025-Q3 |
| UBS Group AG | DOUBLED | 208,901 | 738,818 | +253.7% | $1.4M | 2025-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 330,037 | 419,856 | +27.2% | $801.9K | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 176,183 | 372,190 | +111.3% | $710.9K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 32,482 | 22,398 | -31.0% | $42.8K | 2025-Q3 |
| VANGUARD GROUP INC | ADD | 1,483,350 | 1,891,998 | +27.5% | $5.4M | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 219,766 | 330,037 | +50.2% | $947.2K | 2025-Q2 |
| UBS Group AG | TRIM | 532,535 | 208,901 | -60.8% | $599.5K | 2025-Q2 |
| MORGAN STANLEY | ADD | 133,172 | 176,183 | +32.3% | $505.6K | 2025-Q2 |
| FMR LLC | ADD | 3,270 | 5,296 | +62.0% | $15.2K | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 616,552 | 806,653 | +30.8% | $4.3M | 2025-Q1 |
| UBS Group AG | ADD | 360,617 | 532,535 | +47.7% | $2.9M | 2025-Q1 |
| MORGAN STANLEY | TRIM | 303,289 | 133,172 | -56.1% | $717.8K | 2025-Q1 |
| FMR LLC | NEAR_EXIT | 147,629 | 3,270 | -97.8% | $17.6K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 1,910,458 | 616,552 | -67.7% | $3.3M | 2024-Q4 |
| UBS Group AG | TRIM | 506,465 | 360,617 | -28.8% | $1.9M | 2024-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 3,412,041 | 303,289 | -91.1% | $1.6M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEAR_EXIT | 2,991,409 | 181,217 | -93.9% | $974.9K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 653,257 | 34,974 | -94.6% | $188.2K | 2024-Q4 |
1 unique insiders with 1 transactions. Net insider value: -$14.90 ($0.00 bought, $14.90 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Schiano Dominick | Director | SELL | 266 | $0.0560 | $14.90 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 1 neutral. Avg impact: 6.7/10.
BEARISH
15-12G
7/10
Luminar Technologies, Inc. has filed Form 15-12G to deregister its Class A common stock and suspend
Apr 7, 2026
NEUTRAL
EFFECT
4/10
Luminar Technologies has had eight separate registration statements (Form S-3ASR) become effective a
Mar 12, 2026
BEARISH
8-K
9/10
Luminar Technologies, Inc. and its affiliated debtors have filed for Chapter 11 bankruptcy and are i
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$2.11 mean target
$0.5000 Low
$6.00 High
| Metric | Value |
|---|---|
| Current Price | $0.0180 |
| Target Low | $0.5000 |
| Target Mean | $2.11 |
| Target Median | $1.50 |
| Target High | $6.00 |
| # Analysts | 7 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2025-12-31 |
$-0.11 | $-0.15 | $-0.08 | 92.3% | +93.5% | 2↑ 0↓ | $0.0B | 103.1% | 4 |
| Next Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$-0.49 | $-0.65 | $-0.28 | 94.7% | +93.4% | 2↑ 0↓ | $0.1B | 77.5% | 6 |
| Next FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.110 | |
| 7d ago | $-1.650 | +1.540 |
| 30d ago | $-1.680 | +1.570 |
| 60d ago | $-1.675 | +1.565 |
| 90d ago | $-1.675 | +1.565 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.